Creepy Jar (CRJ) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
23 Apr, 2026Executive summary
Revenue for 2025 was PLN 29.8m, a slight decrease from PLN 31.0m in 2024, with net profit rising to PLN 17.2m from PLN 15.9m year-over-year.
Operating profit increased to PLN 15.9m from PLN 13.9m, and gross profit reached PLN 19.2m, up from PLN 17.9m year-over-year.
Cash flow from operations was PLN 14.8m, while cash at year-end was PLN 22.0m, down from PLN 27.6m.
No significant impact from geopolitical events; business continuity is not at risk.
Financial highlights
Total assets increased to PLN 123.1m from PLN 111.9m year-over-year.
Equity rose to PLN 118.7m from PLN 107.3m, with book value per share at PLN 169.73.
Net margin improved, with net profit at 57.7% of revenue.
Dividend of PLN 7.95m was paid for 2024; 2025 profit allocation pending.
Outlook and guidance
No material post-balance sheet events affecting 2025 results.
Early 2026 saw a successful launch of StarRupture, with 500,000 copies sold and $8.7m gross revenue in 11 days.
Planned capital expenditures for 2026 are PLN 23.5m.
Latest events from Creepy Jar
- Q1 2025 saw record profitability and robust sales, with StarRupture development accelerating.CRJ
Q1 202523 Apr 2026 - Revenue and profit declined in Q3 2025, with focus shifting to StarRupture's upcoming release.CRJ
Q3 202525 Nov 2025 - Revenue fell 17% year-over-year, but margins and cash position remain strong.CRJ
Q4 202411 Nov 2025 - Net profit surged 36% to PLN 8.33 million, with strong margins and a robust cash position.CRJ
Q2 202525 Sep 2025 - Sales and profit dropped in Q3 2024 as StarRupture's launch was delayed and costs rose.CRJ
Q3 202416 Jun 2025 - Revenue and profit fell in H1 2024 as StarRupture investment accelerated.CRJ
Q2 202413 Jun 2025